3Koenneke HC,Nohr R,Leistners M,ct al. Intravenous tPA for is chemic stroke team performance over time, safety, and efficacy in a single cemer, 2-year experience. Stroke ,2001,32 : 1074.
4Lopez-yunez AM, Bruno A, Williams LS, et al. Protocol violation in com- munity-based rtPA stroke treatment are assicoate with symptomatic in- tracere-bral hemorrhage. Stroke,2001,32 : 12.
4Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease andstroke statistics-2011 update : a report from the American HeartAssociation[ J] . Circulation,2011,123(4) :el8-e209.
5Xu ZP, Li H H, Li Y H, et al. Feasibility and outcomes ofintravenous thrombolysis 3-4. 5 hours after stroke in Chinesepatients[J]. J Clin Neurosci, 2014,21 (5) :822-826.
6Tissue plasminogen activator for acute ischemic stroke. TheNational Institute of Neurological Disorders and Stroke rt-PA StrokeStudy Group[J]. N Engl J Med, 1995,333(24) : 1581-1587.
7Braimah J,Kongabie G,Rapp K,et al. Nursing care of acute strokepatients after receiving rt-PA therapy. The NINDS rt-PA Stroke StudyGroup[J]. J Neurosci Nure, 1997 , 29(6) :373-383.
8Koennecke HC, Nohr R, Leistner S, et al. Intravenous tPA forischemic stroke team performance over time, safety, and efficacyin a single-center, 2-year experience[ J] . Stroke,2001,32(5 ):1074-1078.
10Sutter R, Bruder E, Weissenburg M, et al. Thyroid hemorrhagecausing airway obstruction after intravenous thrombolysis for acuteischemic stroke[ J]. Neurocrit Care,2013, 19(3):381-384.
